FDA releases new counterfeit tool
April 26, 2013
THE US FDA has announced a new
public-private partnership to help
identify counterfeit or substandard
anti-malarial medicines.
It utilises an FDA-developed
Counterfeit Detection Device,
codenamed CD-3, with participants
including the Skoll Global Threats
Fund, the US Pharmacopeia, the
National Institutes of Health, the
Centers for Disease Control and
Prevention, and the multi-agency
President’s Malaria Initiative.
The FDA has signed a letter of
intent with Corning Incorporated
to refine and improve the tool for
eventual manufacture on a larger
scale, and in the meantime the
handheld CD-3 will be tested on
the detection of substandard antimalarial
medicines in Africa and
parts of Southeast Asia.
The CD-3 illuminates a product
with a variety of wavelengths of
light to provide a visual comparison
of an unverified product with an
authentic sample.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Apr 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Apr 13